Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790081 | Urologic Oncology: Seminars and Original Investigations | 2018 | 11 Pages |
Abstract
Utilization of SSILN for penile SCC is low and has not changed significantly since the publication of guidelines in the United States. In particular, nonacademic institutions were less likely to adhere to recommendations for performance of SSILNs. We found the omission of SSILNs is associated with a significant increase in mortality.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Solomon L. M.D., Bo Ph.D., Ryan C. M.D., Laura-Maria M.D., Nirmish M.D., Niccolo M. M.D., Timothy N. M.D., Ganesh V. M.D., Ph.D., David S. M.D., Arthur I. M.D., Yair M.D., Yang Ph.D., Vitaly M.D., Aditya M.D.,